Navigation Links
Neogen Develops Simple, Precise Test for Mold Toxin Zearalenone
Date:1/16/2012

LANSING, Mich., Jan. 16, 2012 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) has developed a simple test to detect precise amounts of the mycotoxin zearalenone in grain samples. Zearalenone-contaminated animal feed or grain can cause a wide variety of reproductive problems if eaten by livestock.

Neogen's new Reveal® Q+ for Zearalenone adds to the company's unequaled line of simple, quick, and fully quantitative tests for mycotoxins — a line that also includes tests for the major mycotoxins aflatoxin and deoxynivalenol (DON) in a state-of-the-art format.

"Like our Reveal Q+ tests for aflatoxin and DON, Reveal Q+ for Zearalenone is the easiest test available for rapid, fully quantitative test results," said Neogen's Ed Bradley, vice president of Food Safety. "This innovative technology yields more accurate and reproducible results than other testing methods for zearalenone. The new Reveal Q+ products add to Neogen's unmatched range of simple and accurate lateral flow, microwell, and immunoaffinity column mycotoxin testing options — all of which are backed by the best technical and R&D support in the industry."

After only 6 minutes, Reveal Q+ for Zearalenone delivers precise results ranging from 50 to 1200 parts per billion (ppb) of zearalenone in corn and wheat. Reveal Q+ test strips are read in Neogen's AccuScan® III lateral flow test reader to deliver the precision of more demanding test methods.

"Livestock producers are becoming increasingly aware of zearalenone problems, and have looked for ways to reduce risks related to contaminated feed," Bradley said. "The best protection against mycotoxins is monitoring for their presence in feeds and foods. That means testing along the pathway from initial harvest of grains to the finished products."

Reveal Q+ for Zearalenone offers both room temperature incubation of the test strip and storage of the test kit — eliminating the need for an incubator and refrigeration space. The test requires only minimal equipment to achieve precise results and uses a simple, low cost ethanol extraction process. Ethanol is the preferred extraction solvent of many major grain handlers.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.


'/>"/>
SOURCE Neogen Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Neogen Acquires Gen-Probes BioKits Food Safety Business
2. Neogen Corporation Announces 2nd Quarter Results
3. NeoGenomics Schedules Its Q4 and Full Year 2009 Earnings Release for February 25, 2010
4. Neogen Corporation Announces 1st Quarter Results Conference Call
5. NeoGenomics Schedules its Q3 2010 Earnings Release for October 28, 2010
6. Neogen Again Named to Forbes List of Best Small Companies
7. NeoGenomics Awarded $374,000 in R&D Grants from the US Government
8. Signal Genetics Announces Commercialization Partnership with NeoGenomics Laboratories for Multiple Myeloma Gene Expression Test
9. Diplomat Specialty Pharmacy Develops and Launches Best-In-Class Electronic Navigator (eNAV(TM)) Patient Care System
10. Nventa Develops Proprietary Vaccine Adjuvant
11. Bad News to Bad Bugs: Northern Antibiotics Develops Novel Polymyxins With Reduced Toxicity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), ... Forecasts, 2014 - 2025" report to their offering. ... The Latin American pharmaceutical ... billion by 2025 Low drug registration cost in ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the highest market ... segment is likely to create absolute $ opportunity of a ... By the end of 2027, Cardiology Devices segment is projected ... expanding at a CAGR of 18.4% over the forecast period. ... reprocessed medical devices market in terms of revenue ...
Breaking Medicine Technology:
(Date:4/25/2017)... , ... April 25, 2017 , ... Lake Park Dental ... by using Invisalign® in Lutz, FL. With the help of this highly-effective, ... aesthetics with fewer potential complications, more discretion and less pain. , Drs. Sarah ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Buyers and ... recreational users to dispensaries and head shops –can’t help but be heartened by the ... the tell-tale cannabis odor aptly described as “skunk smell.” At last they can ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
(Date:4/24/2017)... ... April 24, 2017 , ... The Santana Telehealth Project was honored with the ... the American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. , “I ... improve the lives of the poor and underserved in other parts of the world,” ...
(Date:4/24/2017)... ... ... Bright Pink , a national non-profit organization focusing on the prevention and early detection ... Pink is proud to announce Katie Thiede as their new Chief Executive Officer. In January, ... Chairman of the Board and launched a national search to find a visionary new leader ...
Breaking Medicine News(10 mins):